tetano
Editor, Senior Moderator
Eur Heart J Suppl
. 2023 Feb 14;25(Suppl A):A17-A24.
doi: 10.1093/eurheartjsupp/suac110. eCollection 2023 Feb.
Vaccines and cardiovascular outcomes: lessons learned from influenza epidemics
Siva H Yedlapati[SUP] 1 [/SUP], Anuradha Mendu[SUP] 1 [/SUP], Venkat R Tummala[SUP] 2 [/SUP], Sowmith S Maganti[SUP] 2 [/SUP], Khurram Nasir[SUP] 3 [/SUP], Safi U Khan[SUP] 3 [/SUP]
Affiliations
Abstract
Cardiovascular disease (CVD) is the leading cause of death in the world and is largely preventable. An increasing amount of evidence suggests that annual influenza vaccination reduces CVD-related morbidity and mortality. Despite various clinical guidelines recommending annual influenza vaccination for the general population for influenza-like illness risk reduction, with a particular emphasis on people with CVD, vaccination rates fall consistently below the goal established by the World Health Organization. This review outlines the importance of influenza vaccination, mechanisms of cardiovascular events in influenza, summarizing the available literature on the effects of influenza vaccine in CVD and the benefits of influenza vaccine during the COVID-19 pandemic.
Keywords: Cardiovascular disease; Influenza vaccine; Prevention.
. 2023 Feb 14;25(Suppl A):A17-A24.
doi: 10.1093/eurheartjsupp/suac110. eCollection 2023 Feb.
Vaccines and cardiovascular outcomes: lessons learned from influenza epidemics
Siva H Yedlapati[SUP] 1 [/SUP], Anuradha Mendu[SUP] 1 [/SUP], Venkat R Tummala[SUP] 2 [/SUP], Sowmith S Maganti[SUP] 2 [/SUP], Khurram Nasir[SUP] 3 [/SUP], Safi U Khan[SUP] 3 [/SUP]
Affiliations
- PMID: 36937374
- PMCID: PMC10021491
- DOI: 10.1093/eurheartjsupp/suac110
Abstract
Cardiovascular disease (CVD) is the leading cause of death in the world and is largely preventable. An increasing amount of evidence suggests that annual influenza vaccination reduces CVD-related morbidity and mortality. Despite various clinical guidelines recommending annual influenza vaccination for the general population for influenza-like illness risk reduction, with a particular emphasis on people with CVD, vaccination rates fall consistently below the goal established by the World Health Organization. This review outlines the importance of influenza vaccination, mechanisms of cardiovascular events in influenza, summarizing the available literature on the effects of influenza vaccine in CVD and the benefits of influenza vaccine during the COVID-19 pandemic.
Keywords: Cardiovascular disease; Influenza vaccine; Prevention.